Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus

Human Heredity

Volumn 49, Issue 3, 1999, Pages 159-168

  Watanabe, Richard M ^a   Valle, Timo ^b   Hauser, Elizabeth R ^a   Ghosh, Soumitra ^c   Eriksson, Johan ^b   Kohtamäki, Kimmo ^b   Ehnholm, Christian ^b   Tuomilehto, Jaakko ^b   Collins, Francis S ^c   Bergman, Richard N ^d   Boehnke, Michael ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Genetics; Glucose tolerance; Heritability; Pedigree analysis; Variance components

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; TOLBUTAMIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HERITABILITY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL GENETICS; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PEDIGREE ANALYSIS; QUANTITATIVE TRAIT; SIBLING; STATISTICAL ANALYSIS; VARIANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FASTING; FEMALE; FINLAND; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; LIPIDS; MALE; MIDDLE AGED; PEDIGREE; QUANTITATIVE TRAIT, HERITABLE; TOLBUTAMIDE;

EID: 0032980306     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022865     Document Type: Article

References (41)

1. DeFronzo RA: The triumvirate: B-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1997;37:667-687.
2. Bergman RN: Integration of pathogenic factors in impaired glucose tolerance and NIDDM; in Grill V, Efendic S (eds): Pathogenesis of Non-Insulin Dependent Diabetes mellitus. New York, Raven Press, 1988, pp 241-269.
3. Knowler WC, Pettitt DJ, Saad MF, Bennett PH: Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1-27.
4. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
5. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, Kesaniemi Y: Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992;35: 1060-1067.
6. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: Results of a 25-year follow-up study. Lancet 1992;340:925-929.
7. Kenny S, Aubert R, Geiss L: Prevalence and incidence of non-insulin-dependent diabetes; in Harris M (ed): Diabetes in America. Bethesda, National Institutes of Health, 1995, pp 47-67.
8. Beaty T, Fajans SS: Estimating genetic and non-genetic components of variance for fasting glucose levels in pedigrees ascertained through non-insulin dependent diabetes. Ann Hum Genet 1982;46:355-362.
9. Boehnke M, Moll P, Kottke B, Weidman W: Partitioning the variability of fasting plasma glucose levels in pedigrees. Am J Epidemiol 1987;125:679-689.
10. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbot WGH, Knowler WC, Bennett PH, Moll P, Bogardus C: In vivo insulin action is a familial characteristic in nondiabetic Pima Indians. Diabetes 1987;36:1329-1335.
11. Schumaker M, Hasstedt S, Hunt S, Williams R, Elbein SC: Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992; 41:416-423.
12. Sakul H, Pratley R, Cardon L, Ravussin E, Mott D, Bogardus C: Familiality of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in Pima Indians. Am J Hum Genet 1997:60:651-656.
13. Bergman RN: Toward physiological understanding of glucose tolerance. Minimal Model approach. Diabetes 1989;38:1512-1527.
14. Thompson DB, Janssen RC, Ossowki VM, Prochazka M, Knowler WC, Bogardus C: Evidence for linkage between a region on chromosome 1p and the acute insulin response in Pima Indians. Diabetes 1995;44:478-481.
15. Valle T, Tuomilehto J, Bergman RN, Ghosh S, Hauser E, Eriksson J, Nylund S, Kohtamäki K, Tuomilehto-Wolf E, Toivanen L, Vidgren G, Ehnholm C, Blaschak J, Langefeld C, Watanabe RM, Magnuson V, Ally D, Hagopian W, Ross E, Buchanan T, et al: Mapping genes for non-insulin dependent diabetes mellitus: Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care 1998;21:949-958.
16. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man. Measurement of insulin sensitivity and β-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-1467.
17. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of the insulin sensitivity index in man derived by the minmal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
18. Chen M, Porte D Jr: The effect of rate and dose of glucose infusion on the acute insulin response in man. J Clin Endocrinol Metab 1976; 42:1168-1175.
19. McCulloch DK, Bingley P, Colman P, Jackson R, Gale E, The ICARUS Group: Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. Diabetes Care 1993;16: 911-915.
20. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensivitiy and B-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672.
21. Lange K, Westlake J, Spence M: Extensions to pedigree analysis. III. Variance components by the scoring method. Ann Hum Genet 1976;39: 485-491.
22. Lillioja S, Bogardus C: Obesity and insulin resistance: Lessons learned from the Pima Indians. Diabetes Metab Rev 1988;4:517-540.
23. Jacquard A: In The Genetic Structure of Populations. New York, Springer, 1974, p 102.
24. Lange K, Weeks D, Boehnke M: Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 1988;5:471-472.
25. Hopper J, Mathews J: Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet 1982;46:373-383.
26. Boehnke M, Moll P, Lange K, Weidman W, Kottke B: Univariate and bivariate analyses of cholesterol and triglyceride levels in pedigrees. Am J Med Genet 1986;23:775-792.
27. Knuiman M, Divitini M, Welborn T, Bartholomew H: Familial correlations, cohabitation effects, and heritability for cardiovascular risk factors. Ann Epidemiol 1996;6:188-194.
28. Mitchell B, Kammerer C, Blangero J, Mahaney M, Rainwater D, Dyke B, Hixson J, Henkel R, Sharp R, Comuzzie A, Vandeberg J, Stern MP, MacCluer J: Genetic and environmental contributions to cardiovascular risk factors in Mexican Americans. Circulation 1996;94: 2159-2170.
29. Svetkey L, McKeown S, Wilson A: Heritability of salt sensitivity in black Americans. Hypertension 1996;28:854-858.
30. Edwards K. Newman B, Mayer E, Selby J, Krauss RM. Austin M: Heritability of factors of the insulin resistance syndrome in women twins. Genet Epidemiol 1997;14:241-253.
31. Rich SS: Mapping genes in diabetes. Diabetes 1990;39:1315-1319.
32. Elbein SC, Ward WK, Beard JC, Permutt MA: Familial NIDDM molecular-genetic analysis and assessment of insulin action and pancreatic β-cell function. Diabetes 1988;37:377-382.
33. Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS: Familial clustering of insulin sensitivity. Diabetes 1992;41:850-854.
34. Wagenknecht L, Mayer E, Rewers M, Haffner S. Selby J, Borok G, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 1995;5:464-472.
35. Best JD, Kahn SE, Ader M, Watanabe RM, Ni T, Bergman RN: Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996;19:1018-1030.
36. Cerasi E, Efendic S, Luft R: Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1973;i:794-797.
37. Mahtani M, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly M, Weaver A, Brettin T, Duyk G, Lander E, Groop LC: Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996;14: 90-94.
38. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994;93:1120-1130.
39. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl Med 1993;329:1988-1992.
40. Tuomilehto J, Korhonen H, Salomaa J, Stengard J, Aro A, Javela K, Uusitupa M, Pitkäniemi J: Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 1991;20:1010-1017.
41. Tuomilehto J, Missinen A, Kvela S, Pekkanen J, Kaarsalo E, Wolf E, Aro A, Punsar S, Karvonen M: Prevalence of diabetes mellitus in elderly men aged 65 to 84 years in eastern and western Finland. Diabetologia 1986;29:611-615.